Kaléo Redesigns Commercial Team to Increase Support for AUVI-Q® (epinephrine injection, USP)

Kaléo Redesigns Commercial Team to Increase Support for AUVI-Q® 
(epinephrine injection, USP)

Richmond, Virginia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Kaléo, a privately-held U.S. pharmaceutical company has announced a redesign of the...
21 hours ago
from: KSNT 27 News

Continue reading...
Anaphylaxis, Auvi-Q, Epinephrine
More about this